H-FIAGL^IAIV-OH

Ref. 3D-PP42323

Produktinformation

• Name: H-FIAGL^IAIV-OH

Beschreibung

Peptide H-FIAGL^IAIV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FIAGL^IAIV-OH include the following: Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2: Ig fusion protein YD Wang, WF Chen - Clinical immunology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661604002116 Immunogenic SARS-CoV-2 epitopes: in silico study towards better understanding of COVID-19 disease-paving the way for vaccine development V Ranga, E Niemela, MZ Tamirat, JE Eriksson - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/3/408 HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19 S Huang , M Tan - BioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.11.18.388983.abstract Large-scale structure-based screening of potential T cell cross-reactivities involving peptide-targets from BCG vaccine and SARS-CoV-2 RF Tarabini, MM Rigo , A Faustino Fonseca - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.812176/full Prediction of SARS-CoV2 spike protein epitopes reveals HLA-associated susceptibility R JP, P DL, D ML, AR Sandoval - 2020 - europepmc.orghttps://europepmc.org/article/ppr/ppr156133 Synthesis of Killer T Cell Epitopes for Peptide-Based Vaccine of SARS-CoV-2 M Yusuf , A Hardianto , R Maharani - Egyptian Journal of , 2022 - ejchem.journals.ekb.eghttps://ejchem.journals.ekb.eg/article_249734.html Rapid Screen for Antiviral T-Cell Immunity with Nanowire Electrochemical Biosensors M Nami , P Han , D Hanlon, K Tatsuno, B Wei - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202109661 HLA-A* 02 affinity to SARS-CoV-2 and susceptibility to COVID-19 LN Ribeiro, FS Sanches, VM Lelis - European Journal , 2023 - journals.tmkarpinski.comhttp://journals.tmkarpinski.com/index.php/ejbr/article/view/698 Prediction of SARS-CoV2 spike protein epitopes reveals HLA-associated susceptibility JP Romero-Lopez , M Carnalla-Cortes - Res , 2020 - scholar.archive.orghttps://scholar.archive.org/work/ggqtrb3qyfdnzcwdtjfxcbexge/access/wayback/https://assets.researchsquare.com/files/rs-25844/v1.pdf A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1* 01 with COVID-19 fatality in JP Romero-Lopez , M Carnalla-Cortes - Journal of Medical , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26561 Peptides for vaccine development IW Hamley - ACS Applied Bio Materials, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.1c01238 Emerging Technologies for the Treatment of COVID-19 H Aghamollaei , R Sarvestani , H Bakherad - Clinical, biological and , 2021 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-59261-5_7 Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice E Fisher, K Podack, K O'Neill, N Strbo - Frontiers in immunology, 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2020.602254/full?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link Hormozgan Medical Journal A Jandaghi, A Samiei, N Khaghanzadeh - 2022 - scholar.archive.orghttps://scholar.archive.org/work/4bxu4pjxz5gqbeiyjtfc4qrqve/access/wayback/https://hmj.hums.ac.ir/PDF/hmj-3045.pdf

• Marke: Biosynth